Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Polynovo Ltd develops innovative medical devices for a number of medical applications, utilizing the patented biodegradable polymer technology NovoSorb. NovoSorb is a family of proprietary medical-grade polymers that can be utilized to manufacture novel medical devices designed to support tissue repair and which then degrade in a defined fashion in-situ to harmless by-products. The company earns a maximum from the United States of America.
Port Melbourne, VIC, 3207, Australia